PARSIPPANY, N.J--(BUSINESS WIRE)-- COMPANY NAME: ZOETIS INC. HEADLINE: ZOETIS TO ACQUIRE NEXVET FOR US$85 MILLION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY RESTRICTED JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE 13 April 2017 ZOETIS TO ACQUIRE NEXVET FOR US$6.72 IN CASH PER SHARE Acquisition strengthens Zoetis' R&D pipeline in biologics, including monoclonal antibodies for pain and other therapeutic areas in companion animals. Zoetis continues investing in emerging areas to fuel future growth and sustain its leadership in animal health. Parsippany, New...
↧